Based upon these collective findings, autoantibodies that bind to and stimulate TSHR [12], such as M22, and to IGF-1 to stimulate IGF-1R [13,14] have been used in studies of the pathogenesis of GO. This evidence concerns the gene IGF1 and geroderma osteodysplastica.